CMMB vs EIX · $22.2M cap vs P/E 7.3, rev $17.60B
Chemomab Therapeutics Ltd DRC (CMMB) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Chemomab Therapeutics Ltd DRC (CMMB) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
CMMB does not have a complete income-statement cache yet.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
CMMB currently screens at market cap $22.2M. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the CMMB and EIX stock pages for the full models.
Not investment advice.